Stay updated on IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added Results Posted and expanded study details, including Non-Randomized design, Phase 1 and Phase 2 arms, and dosing regimens for Indoximod with Gemcitabine and Nab-Paclitaxel, along with updates to outcomes such as Overall Survival and Progression-Free Survival.
    Difference
    3%
    Check dated 2026-04-10T09:13:19.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.0 instead of Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-20T00:22:02.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-12T20:27:10.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Minor UI/version change: the page footer now shows Revision: v3.4.2, replacing v3.4.1; this does not affect core content, data, or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T03:49:41.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.0 to v3.4.1; a minor UI update that does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T01:27:15.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Glossary is now shown to help users understand trial terms. Minor metadata updates include capitalization adjustments for QC-related labels and a new Revision: v3.4.0 entry.
    Difference
    0.2%
    Check dated 2026-01-28T21:26:16.000Z thumbnail image

Stay in the know with updates to IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial page.